Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy
  • Therapeutic Opportunities
    • Overview
    • Sepsis
    • Community Acquired Pneumonia
    • Emerging Pandemic Threats
    • ESRD Inflammation and Endotoxemia
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Resources

News

News

  • Press Releases
  • Presentations
  • Resources
The Prevalence of Inflammation and Endotoxemia in End-Stage Renal Disease (ESRD)
Feb 23, 2023

The Prevalence of Inflammation and Endotoxemia in End-Stage Renal Disease (ESRD)

Enhancing The Delivery of Chemotherapy and Reducing its Toxicity
Feb 20, 2023

Enhancing The Delivery of Chemotherapy and Reducing its Toxicity

Sigyn Therapy in Action Video
Feb 17, 2022

Sigyn Therapy in Action Video

Sigyn Therapy in Action
Dec 14, 2021

Sigyn Therapy in Action

COVID-19 Cytokine Storm Syndrome

COVID-19 Cytokine Storm Syndrome

The Global Incidence of Sepsis

The Global Incidence of Sepsis

RSS
© 2023 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap